Myth #4: Tirzepatide Is Unsafe or Untested Fact: Tirzepatide (Mounjaro/Zepbound) is FDA-approved and has undergone extensive clinical trials, demonstrating both its efficacy and safety
Menopausal status and hypo-oestrogen risk : age, menopausal transition symptoms, breastfeeding/postpartum status, oophorectomy, cancer endocrine therapy, etc
Being an integral part of popular drugs such as Ozempic and Wegovy, disposable multi-dose prefilled pens provide ease of administration, accuracy of dosing, and improved compliance for diseases including Type 2 Diabetes and obesity
Based on those results, we recommend a specific medication, dosing schedule, and monitoring plan.
Start with the Lowest Dose : Always start with the lowest effective dose and increase only if necessary